Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Special Risks and Management Requirements in Children Receiving Chronic Steroid Therapy

Glucocorticoids are used extensively in the treatment of a wide variety of pediatric illnesses. Although extremely effective as anti-inflammatory and immunosuppressive agents, their use is associated with numerous side effects. Short-term adverse consequences include hyperglycemia, increased appetite and weight gain, fluid retention, mood changes, hypertension, peptic ulceration, and aseptic necrosis of the femoral head. Long-term side effects include osteoporosis, cataracts, myopathy, immunosuppression, and growth failure. In addition, prolonged use of glucocorticoids suppresses the hypothalamic-pituitary-adrenal (HPA) axis.

The impact of exogenous steroid use on the HPA axis depends on:

Amount of steroid used In general, larger than physiologic doses of steroid are required to suppress the axis.







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1996 by the American Academy of Pediatrics.